Neoadjuvant trials in early breast cancer: pathological response at surgery and correlation to longer term outcomes – what does it all mean?

BACKGROUND: Neoadjuvant breast cancer trials are important for speeding up the introduction of new treatments for patients with early breast cancer and for the highly productive translational research which they facilitate. Meta-analysis of trial data shows clear correlation between pathological res...

Descripción completa

Detalles Bibliográficos
Autores principales: Earl, Helena, Provenzano, Elena, Abraham, Jean, Dunn, Janet, Vallier, Anne-Laure, Gounaris, Ioannis, Hiller, Louise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578850/
https://www.ncbi.nlm.nih.gov/pubmed/26391216
http://dx.doi.org/10.1186/s12916-015-0472-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578850/
https://www.ncbi.nlm.nih.gov/pubmed/26391216
http://dx.doi.org/10.1186/s12916-015-0472-7

Ejemplares similares